225 related articles for article (PubMed ID: 33384285)
1. Short-Term Acyl-CoA:Cholesterol Acyltransferase Inhibition, Combined with Apoprotein A1 Overexpression, Promotes Atherosclerosis Inflammation Resolution in Mice.
Amengual J; Ogando Y; Nikain C; Quezada A; Qian K; Vaisar T; Fisher EA
Mol Pharmacol; 2021 Mar; 99(3):175-183. PubMed ID: 33384285
[TBL] [Abstract][Full Text] [Related]
2. ACAT inhibition reduces the progression of preexisting, advanced atherosclerotic mouse lesions without plaque or systemic toxicity.
Rong JX; Blachford C; Feig JE; Bander I; Mayne J; Kusunoki J; Miller C; Davis M; Wilson M; Dehn S; Thorp E; Tabas I; Taubman MB; Rudel LL; Fisher EA
Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):4-12. PubMed ID: 23139293
[TBL] [Abstract][Full Text] [Related]
3. Acyl-CoA:cholesterol acyltransferase inhibition reduces atherosclerosis in apolipoprotein E-deficient mice.
Kusunoki J; Hansoty DK; Aragane K; Fallon JT; Badimon JJ; Fisher EA
Circulation; 2001 May; 103(21):2604-9. PubMed ID: 11382731
[TBL] [Abstract][Full Text] [Related]
4. Direct effect of an acyl-CoA:cholesterol acyltransferase inhibitor, F-1394, on atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice.
Chiwata T; Aragane K; Fujinami K; Kojima K; Ishibashi S; Yamada N; Kusunoki J
Br J Pharmacol; 2001 Aug; 133(7):1005-12. PubMed ID: 11487509
[TBL] [Abstract][Full Text] [Related]
5. Lack of acyl-CoA:diacylglycerol acyltransferase 1 reduces intestinal cholesterol absorption and attenuates atherosclerosis in apolipoprotein E knockout mice.
Chandak PG; Obrowsky S; Radovic B; Doddapattar P; Aflaki E; Kratzer A; Doshi LS; Povoden S; Ahammer H; Hoefler G; Levak-Frank S; Kratky D
Biochim Biophys Acta; 2011 Dec; 1811(12):1011-20. PubMed ID: 21924378
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of PARP inhibition on vascular cell survival and ACAT-1 expression favouring atherosclerotic plaque stability.
Hans CP; Zerfaoui M; Naura AS; Catling A; Boulares AH
Cardiovasc Res; 2008 Jun; 78(3):429-39. PubMed ID: 18245064
[TBL] [Abstract][Full Text] [Related]
7. Loss of apoptosis regulator through modulating IAP expression (ARIA) protects blood vessels from atherosclerosis.
Matsuo K; Akakabe Y; Kitamura Y; Shimoda Y; Ono K; Ueyama T; Matoba S; Yamada H; Hatakeyama K; Asada Y; Emoto N; Ikeda K
J Biol Chem; 2015 Feb; 290(6):3784-92. PubMed ID: 25533470
[TBL] [Abstract][Full Text] [Related]
8. A selective ACAT-1 inhibitor, K-604, stimulates collagen production in cultured smooth muscle cells and alters plaque phenotype in apolipoprotein E-knockout mice.
Yoshinaka Y; Shibata H; Kobayashi H; Kuriyama H; Shibuya K; Tanabe S; Watanabe T; Miyazaki A
Atherosclerosis; 2010 Nov; 213(1):85-91. PubMed ID: 20843517
[TBL] [Abstract][Full Text] [Related]
9. Preventive effects of heregulin-beta1 on macrophage foam cell formation and atherosclerosis.
Xu G; Watanabe T; Iso Y; Koba S; Sakai T; Nagashima M; Arita S; Hongo S; Ota H; Kobayashi Y; Miyazaki A; Hirano T
Circ Res; 2009 Aug; 105(5):500-10. PubMed ID: 19644050
[TBL] [Abstract][Full Text] [Related]
10. Reduced ABCA1-mediated cholesterol efflux and accelerated atherosclerosis in apolipoprotein E-deficient mice lacking macrophage-derived ACAT1.
Su YR; Dove DE; Major AS; Hasty AH; Boone B; Linton MF; Fazio S
Circulation; 2005 May; 111(18):2373-81. PubMed ID: 15851589
[TBL] [Abstract][Full Text] [Related]
11. Preferential pharmacological inhibition of macrophage ACAT increases plaque formation in mouse and rabbit models of atherogenesis.
Perrey S; Legendre C; Matsuura A; Guffroy C; Binet J; Ohbayashi S; Tanaka T; Ortuno JC; Matsukura T; Laugel T; Padovani P; Bellamy F; Edgar AD
Atherosclerosis; 2001 Apr; 155(2):359-70. PubMed ID: 11254906
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein AI) Promotes Atherosclerosis Regression in Diabetic Mice by Suppressing Myelopoiesis and Plaque Inflammation.
Barrett TJ; Distel E; Murphy AJ; Hu J; Garshick MS; Ogando Y; Liu J; Vaisar T; Heinecke JW; Berger JS; Goldberg IJ; Fisher EA
Circulation; 2019 Oct; 140(14):1170-1184. PubMed ID: 31567014
[TBL] [Abstract][Full Text] [Related]
13. Tomatidine, a tomato sapogenol, ameliorates hyperlipidemia and atherosclerosis in apoE-deficient mice by inhibiting acyl-CoA:cholesterol acyl-transferase (ACAT).
Fujiwara Y; Kiyota N; Tsurushima K; Yoshitomi M; Horlad H; Ikeda T; Nohara T; Takeya M; Nagai R
J Agric Food Chem; 2012 Mar; 60(10):2472-9. PubMed ID: 22224814
[TBL] [Abstract][Full Text] [Related]
14. Thieno[2,3-c]isoquinolin-5-one, a potent poly(ADP-ribose) polymerase inhibitor, promotes atherosclerotic plaque regression in high-fat diet-fed apolipoprotein E-deficient mice: effects on inflammatory markers and lipid content.
Hans CP; Zerfaoui M; Naura AS; Troxclair D; Strong JP; Matrougui K; Boulares AH
J Pharmacol Exp Ther; 2009 Apr; 329(1):150-8. PubMed ID: 19124646
[TBL] [Abstract][Full Text] [Related]
15. ApoA1 reduces free cholesterol accumulation in atherosclerotic lesions of ApoE-deficient mice transplanted with ApoE-expressing macrophages.
Boisvert WA; Black AS; Curtiss LK
Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):525-30. PubMed ID: 10073953
[TBL] [Abstract][Full Text] [Related]
16. Chronic infusion of salusin-alpha and -beta exerts opposite effects on atherosclerotic lesion development in apolipoprotein E-deficient mice.
Nagashima M; Watanabe T; Shiraishi Y; Morita R; Terasaki M; Arita S; Hongo S; Sato K; Shichiri M; Miyazaki A; Hirano T
Atherosclerosis; 2010 Sep; 212(1):70-7. PubMed ID: 20684826
[TBL] [Abstract][Full Text] [Related]
17. Adipocyte enhancer-binding protein 1 (AEBP1) (a novel macrophage proinflammatory mediator) overexpression promotes and ablation attenuates atherosclerosis in ApoE (-/-) and LDLR (-/-) mice.
Bogachev O; Majdalawieh A; Pan X; Zhang L; Ro HS
Mol Med; 2011; 17(9-10):1056-64. PubMed ID: 21687917
[TBL] [Abstract][Full Text] [Related]
18. Acyl-coenzymeA (CoA):cholesterol acyltransferase inhibition in rat and human aortic smooth muscle cells is nontoxic and retards foam cell formation.
Rong JX; Kusunoki J; Oelkers P; Sturley SL; Fisher EA
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):122-7. PubMed ID: 15499046
[TBL] [Abstract][Full Text] [Related]
19. SOAT1 deficiency attenuates atherosclerosis by regulating inflammation and cholesterol transportation via HO-1 pathway.
Wu N; Li RQ; Li L
Biochem Biophys Res Commun; 2018 Jun; 501(2):343-350. PubMed ID: 29567472
[TBL] [Abstract][Full Text] [Related]
20. Foam cells in atherosclerosis.
Yu XH; Fu YC; Zhang DW; Yin K; Tang CK
Clin Chim Acta; 2013 Sep; 424():245-52. PubMed ID: 23782937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
